Relevant Clinical Factors in Patients with Myelofibrosis on Ruxolitinib for 5 or More Years.

Relevant Clinical Factors in Patients with Myelofibrosis on Ruxolitinib for 5 or More Years. Acta Haematol. 2023; 146(6):522-529.

View in: PubMed